Isolation identification and drug resistance testing of gram negative bacilli at a tertiary care hospital with special emphasis on the phenotypic and genotypic characterization of carbapenem resistance

Show simple item record

dc.contributor.author Khanduri, Naresh
dc.date.accessioned 2022-09-07T05:42:56Z
dc.date.available 2022-09-07T05:42:56Z
dc.date.issued 2022-09-07
dc.identifier.uri http://hdl.handle.net/123456789/114
dc.description Guide - Agarwal, R K and Chatterjee, B en_US
dc.description.abstract The study included specimens from OPD and IPD patients of all age groups and both sexes. Specimens were cultured on suitable media. Isolates were identified by biochemical methods, both in house and by VITEK 2. Susceptibility to carbapenem drugs (imipenem, meropenem and ertapenem), as well as ampicillin, amoxycillinclavulanate, ampicillin-sulbactam, piperacillin-tazobactam, cephalothin, cefoxitin, cefotaxime, ceftazidime, cefepime, aztreonam, gentamicin, amikacin, ciprofloxacin, levofloxacin, co-trimoxazole, tetracycline, tigecycline, chloramphenicol, and colistin performed by Kirby-Bauer disc diffusion method. A total of 1544 isolates of Gram negative bacilli were studied from different specimens, of which 184 were resistant to one or more carbapenem drugs. Acinetobacter calcoaceticus baumannii complex (104 isolates; 52%) was the dominant species, followed by Pseudomonas aeruginosa (31 isolates; 15.5%). Among the 49 isolates of Enterobacteriaceae, K. pneumoniae was the commonest with 17 (34.6 %) isolates, followed by E. coli with 15 (30.6 %) isolates. Most carbapenem-resistant GNB came from the intensive care units and the neurosurgery ward. The largest numbers of carbapenem-resistant isolates were isolated from pus, urine, and endotracheal tube aspirates. Carbapenem-resistant isolates were generally also resistant to most other antimicrobials except tigecycline and colistin. False-positive carbapenem-resistance Six (10.9%) Enterobacteriaceae isolates appeared to be carbapenem-resistant upon testing with the Kirby-Bauer disc diffusion technique with discs procured from HiMedia. These isolates later turned out to be sensitive when retested with the Kirby-Bauer disc diffusion technique with discs procured from Rosco Diagnostica, Denmark, and also by the Etest method, resulting in a false-positivity rate of 10.9% for disc diffusion. In addition, four isolates of Stenotrophomonas maltophilia and six isolates of Elizabethkingia meningoseptica had to be left out of the study because they are intrinsically resistant to carbapenem Minimum Inhibitory Concentration The Etest method for minimum inhibitory concentration (MIC) showed that the carbapenem MICs of most resistant isolates were ≥32 μg/ml. The remaining 184 isolates were then tested for carbapenemase enzymes and efflux pumps by phenotypic and genotypic methods. PHENOTYPIC METHODS Modified Hodge Test (MHT) Of the 184 isolates tested by MHT, only 22 tested positive. Rosco KPC and MBL detection kit Of the 49 Enterobacteriaceae isolates, 40 were MBL positive, 2 were both MBL and KPC positive and the remainder did not produce any of the enzymes and were presumed to be resistant by other mechanisms. Rosco Rapid CARB Blue kit 43 (41.3%) Acinetobacter, 13 (41.9%) P. aeruginosa & 39 (79.5%) Enterobacteriaceae isolates showed the presence of carbapenemases by this kit. Rosco Neo Rapid CARB kit The Enterobacteriaceae and Pseudomonas isolates were then tested by Rosco neo rapid CARB kit. 40 (81.6%) Enterobacteriaceae isolates and 16 (51.6 %) P. aeruginosa isolates were tested positive as carbapenemase producers Carba NP test, CarbAcineto NP and Blue Carba tests with modifications Overall 45 (91.8%) Enterobacteriaceae and 19 (61.2%) P. aeruginosa isolates were found to be positive for carbapenemase production by Carba NP and Blue Carba tests Overall 84.6% Acinetobacter calcoaceticus baumannii were positive by CarbAcineto NP and Blue Carba test for the carbapenemase detection. In terms of modifications, no difference in results was found regarding the source of imipenem while in three (6.25 %) Enterobacteriaceae isolates carbapenemase production was found to be inducible by imipenem Carbapenem inactivation method (CIM) Of the resistant isolates, 73 (70.1%) Acinetobacter spp., 15 (48.3%) P. aeruginosa and 38 (77.5%) Enterobacteriaceae isolates were tested positive for carbapenemase activity by this test. GENOTYPIC METHODS Detection of different carbapenemase genes Majority of the isolates showed the presence of NDM-1 carbapenemase gene. In addition to NDM-1gene, the isolates also showed the presence of VIM and OXA-48 genes. Majority (83.3 %) of the VIM positive were P. aeruginosa. OXA-48 was detected in only K. pneumoniae isolates. None of the study isolate found to be positive for KPC gene. EFFLUX PUMP ACTIVITY The presence of efflux was detected by two methods namely ethidium bromide cartwheel method and agar dilution method using reserpine as efflux inhibitor Ethidium bromide cartwheel method On performing the efflux protocol 27 isolates were found to be positive. i.e. (the strains showing little or no fluorescens under UV light) Reserpine as efflux pump inhibitor Only 20 isolates showed a decrease in the MIC of meropenem when reserpine was added. en_US
dc.language.iso en_US en_US
dc.publisher SRHU en_US
dc.subject Antibiotic drugs en_US
dc.subject Antibiotics en_US
dc.subject Bacilli en_US
dc.subject Bacterial infection en_US
dc.subject Carbapenem en_US
dc.subject Ertapenem en_US
dc.subject Imipenem en_US
dc.subject Life Sciences,Microbiology,Microbiology en_US
dc.title Isolation identification and drug resistance testing of gram negative bacilli at a tertiary care hospital with special emphasis on the phenotypic and genotypic characterization of carbapenem resistance en_US
dc.type Thesis en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search Himalayan


Advanced Search

Browse

My Account